Patent Expiry
SUPN: OXTELLAR XR: recorded patent 10220042 expiry
April 13, 2027 · OXCARBAZEPINE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- April 13, 2027
- Company
- SUPERNUS PHARMACEUTICALS, INC. (SUPN)
- Drug
- OXCARBAZEPINE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
OXTELLAR XR: recorded patent 10220042 expiry
Orange Book application NDA202810, product 001, listed patent 10220042 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- OXCARBAZEPINE